Support Platform for Type 1 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if an online training and support platform can improve how adults manage their type 1 diabetes (T1D). Participants will use the platform either as part of their usual medical care or independently alongside their regular care. The goal is to understand if the platform aids self-management and what factors influence its ease of use in real-world settings. Individuals with T1D who live in Canada, have internet access, and can understand English or French may be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative diabetes management solutions.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using an online platform for diabetes management, so you likely won't need to change your medication routine.
What prior data suggests that this online training and support platform is safe for adults with type 1 diabetes?
Research has shown that the Support platform is generally easy for people to use. In an initial study, participants reported high satisfaction after using the platform for six months, suggesting it is simple and comfortable.
The platform is designed to help people with type 1 diabetes manage their condition more effectively. It offers online training and peer support, accessible whenever needed. No reports of serious side effects have emerged from using the platform, likely because it is a digital tool providing information and support, rather than a medication or medical procedure.
Overall, the Support platform appears safe for users, aiding in diabetes management without causing harm.12345Why are researchers excited about this trial?
Researchers are excited about the Support platform for Type 1 Diabetes because it integrates digital tools directly into a patient's regular diabetes care, potentially enhancing the support they receive. Unlike standard treatments that may rely heavily on in-person consultations and manual data tracking, this platform offers a more seamless, tech-driven approach that can be accessed either as part of routine care or independently. This flexibility allows for tailored support, adapting to each patient's needs and potentially improving their self-management and engagement. By leveraging technology, this platform could provide real-time feedback and a more personalized experience, which is a significant step forward from conventional methods.
What evidence suggests that this support platform is effective for type 1 diabetes self-management?
Research has shown that the Support platform can help people with type 1 diabetes manage their condition more effectively. In earlier studies, users of the platform improved their blood sugar control, particularly by lowering their HbA1c levels, an important measure of long-term blood sugar. In this trial, participants will be divided into two groups: one group will integrate the Support platform into their usual care, while the other group will access the platform independently from their regular care. The platform offers online training and support from others with diabetes, which has been linked to increased confidence in managing the condition. It also helps individuals feel more prepared to handle their diabetes as they transition from youth to adulthood. Overall, this online tool is designed to make managing diabetes easier and more effective by providing self-guided learning and connections with peers.12367
Who Is on the Research Team?
Anne-Sophie Brazeau, PhD
Principal Investigator
School of human nutrition - McGill University
Are You a Good Fit for This Trial?
This trial is for adults in Canada with Type 1 Diabetes, including latent autoimmune diabetes. Participants must have internet access, an active email address, and understand English or French.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline online questionnaires and receive access to the Support platform
Intervention
Participants use the Support platform for diabetes self-management, with access either integrated into usual care or independently
Follow-up
Participants complete follow-up online questionnaires and share glucose data at 6 and 12 months
What Are the Treatments Tested in This Trial?
Interventions
- Support platform
Trial Overview
The study tests if an online support platform improves self-management of Type 1 Diabetes. One group uses the platform through their clinic; another accesses it independently. They'll use it for a year and share data with researchers.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
PWT1D participants will have access to Support as part of their regular care (their HCPs will use Support in their care). PWT1D participants in ARM 1 are followed in one of the 4 participating clinics either in-person or remotely or hybrid.
PWT1D participants will have access to Support, independently from their regular care (they may initiate discussion about the platform with their diabetes care team who might register themselves on the platform, but will not prompt to any specific section on the platform and will not receive any training about the platform). PWT1D participants in ARM 2 can be followed in any other clinics in Canada.
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGill University
Lead Sponsor
Institut de Recherches Cliniques de Montreal
Collaborator
Centre de médecine métabolique de Lanaudière
Collaborator
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborator
Centre Hospitalier de l'Universite Laval (CHUL)
Collaborator
Centre Hospitalier de l'Université Laval
Collaborator
Citations
Support-t, an online training and peer support platform to ...
Our primary outcome is haemoglobin A1c (HbA1c) at 18 months (effectiveness outcome). Secondary outcomes include change in self-efficacy for ...
Support-t, an online training and peer support platform to ...
Secondary outcomes include self-efficacy for diabetes self-management, transition readiness, diabetes-specific quality of life, diabetes ...
3.
diabetesjournals.org
diabetesjournals.org/care/article/47/8/e54/156793/The-Support-Pro-Online-Training-PlatformThe Support-Pro Online Training Platform: Increasing Health ...
The online bilingual (English and French) Support platform aims to facilitate diabetes self-management through self-guided education with regular updates.
protocol of an effectiveness-implementation trial
Support-t , an online training and peer support platform to accompany youth living with type 1 diabetes transitioning to adult healthcare: ...
How online peer support affects management efficacy and ...
Peer-support groups on social media platforms can serve as sources of the necessary information, support, and feedback on diabetes management competence.
6.
diabetesjournals.org
diabetesjournals.org/diabetes/article/70/Supplement_1/451-P/140011/451-P-Participants-Satisfaction-with-the-Support451-P: Participants' Satisfaction with the Support Online Self ...
This proof-of-concept study aims to evaluate the satisfaction of adults with T1D using the SUPPORT platform after 6 months.
Findings from a pilot clinical trial | PLOS Digital Health
In short, this digital platform shows real potential to improve the way families and healthcare teams manage type 1 diabetes together. It could lead to more ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.